Topical calcineurin inhibitors (TCIs) are a class of medications that modulate the immune system by inhibiting the enzyme calcineurin. This action reduces the activity of T-cells, thereby decreasing inflammation and autoimmune responses. Common TCIs include tacrolimus and pimecrolimus.
